DCGI approves Phase 2 and 3 clinical trial of COVAXIN in the age group of 2 to 18 Years Leave a Comment / TC / CS SURBHI SAXENA / May 13, 2021 / age group 2 to 18 years, Bharat Biotech ltd, covaxin, COVID, COVID vaccine, COVID-19
